Cost-effective clinical outcomes and patient safety are the highest priorities in today's healthcare environment. Biomedical technology companies play their part in helping to meet these priorities. There are many factors that can contribute to critical incidents in the routine operation of a hospital or clinical practice. This places complex demands on the state-of-the-art biomedical technology used in clinical environments. To prevent and minimise the possibility of critical incidents, the medical technology provider must adhere to the latest international standards for product design and manufacture. This approach is intended to deliver effective products that are safe and reliable. inomed, working with leading clinical innovation leaders around the world, delivers high-quality reliable products for routine clinical use. Our approach to clinical product design delivers an easy to use product that enables the clinician to deliver effective patient diagnostics, monitoring (IONM) and treatment. We do this within safe technical parameters, minimising risk to the patient. Patient safety and successful outcomes are our priority.
inomed develops and manufactures state-of-the-art products and treatments in the fields of intraoperative neuromonitoring (IONM), functional neurosurgery, pain treatment and neurological diagnostics.
inomed has been developing medical technology products for more than 25 years. Our team of clinicians, technologists and product specialists bring together the very best clinical development and validation techniques to medical device technology we deliver to customers. The effort required to deliver useful clinical products includes a strong commitment to innovation and many years of clinical trials. Our team works on an interdisciplinary basis, where the focus is to meet the needs of the medical practitioner and produce medical technology products that deliver fast, accurate and reliable results.
We conduct extensive research and development into new techniques and technologies – with the patient as our primary focus. This results in the mitigation of risk to patients and clinicians during the normal use of our products. Neurological investigation and intervention is a challenging field and has a long history. Our purpose is to help the clinician minimise negative outcomes and deliver improved patient care – resulting in improvements to the quality of life for patients. The technology and innovation from inomed has proved valuable and helped to set new milestones in the fields of diagnosis, surgical intervention and therapy. inomed is the choice when it comes to ensuring medical treatment is safe, progressive and effective.
It is with great sadness that we said goodbye to our esteemed company founder and CEO Rudi Mattmüller, who passed away on 22 May 2023 after a serious illness.
More than 30 years ago, Rudi Mattmüller laid the foundation for the inomed Group and successfully shaped the development of the company over many years. With his innovative ideas and his extraordinary personality, he has had a decisive influence on an entire industry.
With the death of Rudi Mattmüller, we lose a person and a friend to whom we own a great deal. Due to his friendly nature and professional expertise, Rudi Mattmüller was respected and appreciated by everyone. He will always remain a role model for us and we will honour his memory. Our deepest sympathy goes to his family.
Feel free to leave your message in our online book of condolence. >>
The management board and employees of the inomed Group
Further information on the award of the "TOP 100" seal 2022 by the renowned company compamedia GmbH can be found here. >>
The entire company will be reachable as usual.
Our production continues and our ability to deliver will not be impaired.
If you have any questions, please do not hesitate to contact us.